What is a Value Stock?
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:
- Innoviva INVA - P/E: 5.24
- Sage Therapeutics SAGE - P/E: 2.89
- Sonida Senior Living SNDA - P/E: 0.62
- National Healthcare NHC - P/E: 6.65
- InVivo Therapeutics Hldg NVIV - P/E: 1.09
Innoviva has been featured as a value stock. Innoviva's Q3 EPS sits at 0.9, which has not changed since last quarter (Q2). Innoviva does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Sage Therapeutics's earnings per share for Q3 sits at -2.21, whereas in Q2, they were at -1.83. Sage Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Sonida Senior Living saw a decrease in earnings per share from 23.49 in Q2 to 17.48 now. Sonida Senior Living does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
National Healthcare saw a decrease in earnings per share from 0.98 in Q2 to 0.96 now. The company's most recent dividend yield sits at 3.05%, which has increased by 0.33% from 2.72% last quarter.
InVivo Therapeutics Hldg has been featured as a value stock. InVivo Therapeutics Hldg's Q3 EPS sits at -0.07, which has not changed since last quarter (Q2). InVivo Therapeutics Hldg does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.